The official opening of the newest Synexus dedicated research site, in Berlin Germany, took place on Thursday, 9th November 2017.
Iwona Tongbhoyai, Managing Director, Synexus Clinical Research GmbH commented: “Our newly opened Dedicated Research Site in Berlin is an important milestone in our strategic development as a patient focused research organisation in Germany. By providing larger, innovative trial centres, we want to give more patients access to modern clinical medicine, enhance their positive experience of our services and offer our customers added value. With its outstanding medical expertise, highly-quality clinical trials and excellent access to patients, Germany is one of the leading locations for the implementation of clinical trials”.
Synexus has a strong presence in Germany with its four proprietary Clinical Research Centres in Berlin, Leipzig, Bochum and Frankfurt. Synexus gives approximately eight million potential patients in Germany access to modern medicine by participating in clinical trials.